Keyphrases
Genetic Studies
100%
Rare Variants
100%
Asthma
100%
Multi-ethnic
100%
Severe Symptoms
100%
Agonist Treatment
100%
Severe Exacerbations
100%
Symptom Control
100%
ADRB2
100%
Non-Hispanic White
87%
White Patients
62%
African American Patients
50%
Odds Ratio
37%
Life-threatening
25%
Complex Allele
25%
Hospital Admission
25%
Ethnic Groups
25%
Safety Study
25%
Clinical Trials
12%
Adverse Events
12%
Oligonucleotides
12%
Meta-analysis
12%
U.S. Food
12%
African American
12%
Receptor Gene
12%
Therapeutic Response
12%
NsSNPs
12%
Hospitalization Rate
12%
At-risk
12%
Severe Adverse Events
12%
White Americans
12%
Homozygote
12%
Healthcare Visits
12%
Adrenergic Receptors
12%
Susceptible Population
12%
Predictive Biomarker
12%
U.S. National Institutes of Health
12%
Persistent Symptoms
12%
Systemic Corticosteroids
12%
Severe Asthma Exacerbation
12%
Boxed Warning
12%
Puerto Ricans
12%
Gly16Arg
12%
Medicine and Dentistry
Allele
100%
Asthma
100%
Patient with Asthma
50%
Odds Ratio
50%
Adverse Event
33%
Ethnic Group
33%
Biological Marker
16%
Treatment Response
16%
Single Nucleotide Polymorphism
16%
Health Care
16%
Clinical Trial
16%
Promoter Region
16%
Meta-Analysis
16%
Outpatient
16%
Asthma Exacerbation
16%
Severe Asthma
16%
Adrenergic Receptor
16%
Receptor Gene
16%
Homozygote
16%
Polynucleotide
16%
Biochemistry, Genetics and Molecular Biology
Genetics
100%
Allele
100%
Agonist
100%
Rare Variant
100%
Single-Nucleotide Polymorphism
16%
Clinical Trial
16%
Promoter Region
16%
Receptor Gene
16%
Homozygote
16%
Adrenergic Receptor
16%
Polynucleotide
16%
Immunology and Microbiology
Asthma
100%
Allele
100%
Agonist
100%
Replication
33%
Severe Asthma
16%
Promoter Region
16%
Single Nucleotide Polymorphism
16%
Receptor Gene
16%
Asthma Exacerbation
16%
Homozygote
16%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
100%
Adverse Event
33%
Clinical Trial
16%
Biological Marker
16%
Adrenergic Receptor
16%
Polynucleotide
16%